Gerardo J Alanis-Funes

Prof. Gerardo J Alanis-Funes

Tec de Monterrey, Campus Monterrey
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Cancers
Verified
Journal Article
Open access
PDF file
RBRubén Rodríguez Bautista
Rubén Rodríguez Bautista
CCClaudia H. Caro-Sánchez
Claudia H. Caro-Sánchez
PCPaula Cabrera-Galeana
Paula Cabrera-Galeana
Gerardo J Alanis-FunesGerardo J Alanis-Funes
Gerardo J Alanis-Funes
EGEverardo Gutierrez-Millán
Everardo Gutierrez-Millán
OAOscar Arrieta
Oscar Arrieta
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease. Seven subtypes have been described based on gene expression patterns. Herein, we characterized the tumor biology and clinical behavior of the immunomodulatory (IM) subtype. Methods: Formalin-fixed paraffin-embedded tumor samples from 68 high-risk (stage III-IV) TNBC patients were analyzed through microarrays, immunohistochemistry, and DNA sequencing. Results: The IM subtype was identified in 24% of TNBC tumor samples and characterized by a higher intratumoral (intT) and stromal (strml) infiltration of FOXP3+ TILs (Treg) compared with non-IM subtypes. Further, PD-L1+ (>1%) expression was significantly higher, as well as CTLA-4+ intT and strml expression in the IM subtype. Differential expression and gene set enrichment analysis identified biological processes associated with the immune system. Pathway analysis revealed enrichment of the β-catenin signaling pathway. The non-coding analysis led to seven Long Intergenic Non-Protein Coding RNAs (lincRNAs) (6 up-regulated and 1 down-regulated) that were associated with a favorable prognosis in the TNBC-IM subtype. The DNA sequencing highlighted two genes relevant to immune system responses: CTNNB1 (Catenin β-1) and IDH1. Conclusion: the IM subtype showed a distinct immune microenvironment, as well as subtype-specific genomic alterations. Characterizing TNBC at a molecular and transcriptomic level might guide immune-based therapy in this subgroup of patients.

18 July 2022 in Genes
Verified
Journal Article
Open access
PDF file
Gerardo J Alanis-FunesGerardo J Alanis-Funes
Gerardo J Alanis-Funes
SASaul Lira Albarran
Saul Lira Albarran
JHJesús Hernández-Pérez
Jesús Hernández-Pérez
MGMario A. Garza-Elizondo
Mario A. Garza-Elizondo
RORocio Ortiz-Lopez
Rocio Ortiz-Lopez
Claudia Rangel-EscareñoClaudia Rangel-Escareño
Claudia Rangel-Escareño
No genetic basis is currently established that differentiates hypermobility spectrum disorders (HSD) from hypermobile Ehlers–Danlos syndrome (hEDS). Diagnosis is entirely based on clinical parameters with high overlap, leading to frequent misdiagnosis of these two phenotypes. This study presents a landscape of DNA mutations through whole-exome sequencing of patients clinically diagnosed with generalized HSD. In this study, three genes (MUC3A, RHBG, and ZNF717) were mutated in all five patients evaluated. The functional enrichment analysis on all 1162 mutated genes identified the extracellular matrix (ECM) structural constituent as the primary overrepresented molecular function. Ingenuity pathway analysis identified relevant bio-functions, such as the organization of ECM and hereditary connective tissue disorders. A comparison with the matrisome revealed 55 genes and highlighted MUC16 and FREM2. We also contrasted the list of mutated genes with those from a transcriptomic analysis on data from Gene Expression Omnibus, with only 0.5% of the genes at the intersection of both approaches supporting the hypothesis of two different diseases that inevitably share a common genetic background but are not the same. Potential biomarkers for HSD include the five genes presented. We conclude the study by describing five potential biomarkers and by highlighting the importance of genetic/genomic approaches that, combined with clinical data, may result in an accurate diagnosis and better treatment.

20 March 2020 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
RARene Arredondo-Hernandez
Rene Arredondo-Hernandez
MSMax Schmulson
Max Schmulson
POPatricia Orduña
Patricia Orduña
GLGamaliel López-Leal
Gamaliel López-Leal
AZAngel-Mario Zarate
Angel-Mario Zarate
CHConsorcio Mexicano Para el Estudio del Microbioma Humano
Consorcio Mexicano Para el Estudio del Microbioma Humano
Irritable bowel syndrome (IBS) is the most frequent functional gastrointestinal disorder, worldwide, with a high prevalence among Mestizo Latin Americans. Because several inflammatory disorders appear to affect this population, a further understanding of host genomic background variants, in conjunction with colonic mucosa dysbiosis, is necessary to determine IBS physiopathology and the effects of environmental pressures. Using a simple polygenic model, host single nucleotide polymorphisms (SNPs) and the taxonomic compositions of microbiota were compared between IBS patients and healthy subjects. As proof of concept, five IBS-Rome III patients and five healthy controls (HCs) were systematically studied. The human and bacterial intestinal metagenome of each subject was taxonomically annotated and screened for previously annotated IBS, ulcerative colitis, and Crohn´s disease-associated SNPs or taxon abundance. Dietary data and fecal markers were collected and associated with the intestinal microbiome. However, more than 1,000 variants were found, and at least 76 SNPs differentiated IBS patients from HCs, as did associations with 4 phyla and 10 bacterial genera. In this study, we found elements supporting a polygenic background, with frequent variants, among the Mestizo population, and the colonic mucosal enrichment of Bacteroides, Alteromonas, Neisseria, Streptococcus, and Microbacterium, may serve as a hallmark for IBS

25 April 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
JRJudit A. Ramírez-Rosete
Judit A. Ramírez-Rosete
AHAlonso Hurtado-Vazquez
Alonso Hurtado-Vazquez
AMAntonio Miranda-Duarte
Antonio Miranda-Duarte
SPSergio Peralta-Cruz
Sergio Peralta-Cruz
RCRamiro Cuevas-Olivo
Ramiro Cuevas-Olivo
Alberto Hidalgo-BravoAlberto Hidalgo-Bravo
Alberto Hidalgo-Bravo
Diagnosis of developmental dysplasia of the hip (DDH) mostly relies on physical examination and ultrasound, and both methods are operator-dependent. Late detection can lead to complications in young adults. Current evidence supports the involvement of environmental and genetic factors, such as single nucleotide variants (SNVs). Incorporating genetic factors into diagnostic methods would be useful for implementing early detection and management of affected individuals. Our aim was to analyze environmental factors and SNVs in DDH patients. We included 287 DDH cases and 284 controls. Logistic regression demonstrated an association for sex (OR 9.85, 95% CI 5.55–17.46, p = 0.0001), family history (OR 2.4, 95% CI 1.2–4.5, p = 0.006), fetal presentation (OR 3.19, 95% CI 1.55–6.54, p = 0.002), and oligohydramnios (OR 2.74, 95%CI 1.12–6.70, p = 0.026). A model predicting the risk of DDH including these variables showed sensitivity, specificity, PPV, and NPV of 0.91, 0.53, 0.74, and 0.80 respectively. The SNV rs1800470 in TGFB1 showed an association when adjusted for covariables, OR 0.49 (95% CI 0.27–0.90), p = 0.02. When rs1800470 was included in the equation, sensitivity, specificity, PPV and NPV were 0.90, 0.61, 0.84, and 0.73, respectively. Incorporating no-operator dependent variables and SNVs in detection methods could be useful for establishing uniform clinical guidelines and optimizing health resources.

1 October 2025 in Cancers
Verified
Journal Article
Open access
PDF file
RBRubén Rodríguez Bautista
Rubén Rodríguez Bautista
CCClaudia H. Caro-Sánchez
Claudia H. Caro-Sánchez
PCPaula Cabrera-Galeana
Paula Cabrera-Galeana
Gerardo J Alanis-FunesGerardo J Alanis-Funes
Gerardo J Alanis-Funes
EGEverardo Gutierrez-Millán
Everardo Gutierrez-Millán
OAOscar Arrieta
Oscar Arrieta
A Fine–Gray analysis was missing in the original version